Published in Semin Fetal Neonatal Med on February 19, 2012
Nutrition practice, compliance to guidelines and postnatal growth in moderately premature babies: the NUTRIQUAL French survey. BMC Pediatr (2015) 0.81
Short-term respiratory outcomes in late preterm infants. Ital J Pediatr (2014) 0.81
Intensity of delivery room resuscitation and neonatal outcomes in infants born at 33 to 36 weeks' gestation. J Perinatol (2015) 0.80
Development and Validation of Educational Leaflet for Caregivers of Preterm Infants. J Clin Diagn Res (2016) 0.80
Low and moderate prenatal ethanol exposures of mice during gastrulation or neurulation delays neurobehavioral development. Neurotoxicol Teratol (2015) 0.77
Sustained lung inflation in late preterm infants: a randomized controlled trial. J Perinatol (2016) 0.75
The transition from intra to extra-uterine life in late preterm infant: a single-center study. Ital J Pediatr (2016) 0.75
Placental infarction probably associated with late term premature delivery. J Surg Case Rep (2014) 0.75
Gestational age and 1-year hospital admission or mortality: a nation-wide population-based study. BMC Pediatr (2017) 0.75
Respiratory system involvement in Costello syndrome. Am J Med Genet A (2016) 0.75
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol (1988) 3.92
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation (1998) 1.73
Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res (2000) 1.70
Decision analysis for the assessment of a record linkage procedure: application to a perinatal network. Methods Inf Med (2005) 1.52
[Urinary tract infections in children]. Arch Pediatr (2009) 1.40
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res (1986) 1.24
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol (2005) 1.22
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett (2000) 1.15
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur J Cancer (1993) 1.10
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol (1996) 1.09
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Bone Marrow Transplant (2009) 1.07
Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. Eur J Endocrinol (2007) 1.06
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. Oncogene (2011) 0.99
Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer (2001) 0.99
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant (2005) 0.98
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. Ann Oncol (2006) 0.94
90K (Mac-2 BP) in human milk. Clin Exp Immunol (1996) 0.94
Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res (1995) 0.93
Advantages and limitations of using national administrative data on obstetric blood transfusions to estimate the frequency of obstetric hemorrhages. J Public Health (Oxf) (2012) 0.93
Severe respiratory disorders in term neonates. Paediatr Perinat Epidemiol (2008) 0.91
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int J Cancer (1996) 0.91
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children. J Clin Immunol (2000) 0.90
Induced protein synthesis and oestradiol binding to the nuclei in the rat uterus. Nat New Biol (1973) 0.90
Biochemistry of cervical mucus: a comparative analysis of the secretion from preovulatory, postovulatory, and pregnancy periods. Fertil Steril (1971) 0.90
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1993) 0.90
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. AIDS Res Hum Retroviruses (1993) 0.89
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study. J Clin Oncol (2004) 0.89
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br J Cancer (2010) 0.89
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Ann Oncol (2012) 0.89
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections. Clin Exp Immunol (1999) 0.88
Unknown primary tumors. Biochim Biophys Acta (2011) 0.88
Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo. Blood (2000) 0.88
The effect of parenteral nitrogen and energy intake on electrolyte balance in the preterm infant. Eur J Clin Nutr (2011) 0.88
Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol (1988) 0.88
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells. Int J Cancer (1998) 0.88
Epidermal growth factor receptor expression in gynecological malignancies. Gynecol Obstet Invest (1989) 0.88
Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line. Breast Cancer Res Treat (1983) 0.87
Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease. Br J Cancer (1993) 0.87
Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial. Neonatology (2006) 0.87
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res (1991) 0.86
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study. Oncol Rep (2006) 0.85
[Using discharge abstracts as a tool to assess a regional perinatal network]. Rev Epidemiol Sante Publique (2001) 0.85
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients. Br J Haematol (1993) 0.85
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study. Oncol Rep (2010) 0.85
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study. J Clin Oncol (1991) 0.84
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L. Arch Pathol Lab Med (1998) 0.84
Recombinant alpha-2b-interferon dynamic test as a potential tool in predicting disease status during second look in ovarian cancer. A preliminary report. Cancer (1991) 0.84
Unusually high level of a tumor-associated antigen in the serum of human immunodeficiency virus-seropositive individuals. J Infect Dis (1991) 0.84
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells. Int J Cancer (1994) 0.83
PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites. Oncogene (2001) 0.83
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies. Cancer (1990) 0.83
Tumor-associated antigen 90K activates myelomonocytic cell line THP-1. Cancer Lett (1996) 0.82
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2013) 0.82
Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia. Oncology (1987) 0.82
Tyrosine kinase inhibitors. Curr Cancer Drug Targets (2010) 0.82
Biochemical changes during progesterone-induced maturation in Xenopus laevis oocytes. Mol Cell Biochem (1974) 0.82
[Liveborn birth-weight of single and uncomplicated pregnancies between 28 and 42 weeks of gestation from Burgundy perinatal network]. J Gynecol Obstet Biol Reprod (Paris) (2008) 0.82
DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications. Cancer (1993) 0.82
Similarly increased congenital anomaly rates after intrauterine insemination and IVF technologies: a retrospective cohort study. Hum Reprod (2012) 0.81
Expression of the 90K immunostimulator gene is controlled by a promoter with unique features. J Biol Chem (1997) 0.81
Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme. Epidemiol Infect (2011) 0.81
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients. Cancer Chemother Pharmacol (1999) 0.81
Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age <32 weeks. J Perinatol (2008) 0.81
High-dose (200 mg/m2) cisplatin-induced neurotoxicity in primary advanced ovarian cancer patients. Cancer Treat Rep (1987) 0.81
Immunohistochemical localization of creatine kinase BB in primary breast cancer: correlation with estrogen receptor content. J Cancer Res Clin Oncol (1988) 0.81
A Population-Based Study of Meconium Aspiration Syndrome in Neonates Born between 37 and 43 Weeks of Gestation. Int J Pediatr (2011) 0.81
Glucocorticoids inhibit the stimulatory effect of epidermal growth factor on the initiation of DNA synthesis. J Cell Physiol (1981) 0.80
The immune stimulatory protein 90K increases major histocompatibility complex class I expression in a human breast cancer cell line. Biochem Biophys Res Commun (1996) 0.80
Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitis. Am J Gastroenterol (1995) 0.80
Estrogen responsive creatine kinase in normal and neoplastic cells. J Steroid Biochem (1981) 0.80
Predictive value of multiple tumor marker assays in second-look procedures for ovarian cancer. Gynecol Oncol (1989) 0.80
Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer. Anticancer Res (1988) 0.80
Fluid and electrolyte intake during the first week of life in preterm infants receiving parenteral nutrition according current guidelines. Minerva Pediatr (2010) 0.80
Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family. Clin Exp Immunol (1998) 0.79
Temporal trend in the level of 90K glycoprotein after HIV seroconversion among persons coinfected with hepatitis C virus. Infection (2005) 0.79
Estrogen stimulates cell proliferation and the increase of a 52,000 dalton glycoprotein in human breast cancer cells. J Steroid Biochem (1984) 0.79
[Significance of lactose breath test in the newborn]. Minerva Pediatr (1995) 0.79
The gene (LGALS3BP) encoding the serum protein 90K, associated with cancer and infection by the human immunodeficiency virus, maps at 17q25. Cytogenet Cell Genet (1995) 0.79
Discussion about switch strategy in the adjuvant hormonal therapy of breast cancer: psychological aspects of physician-patient communication. Ann Oncol (2009) 0.79
Isolation and functional characterization of the human 90K promoter. Genomics (1999) 0.79
Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice. Toxicol Lett (2009) 0.79
Hypoproteinemia on the first day of life and adverse outcome in very preterm infants admitted to the neonatal intensive care unit. J Perinatol (2011) 0.79
Effect of thyroid hormones on androgen responsiveness in a mammary tumor cell line. J Steroid Biochem (1981) 0.78
Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression. J Infect Dis (1991) 0.78
Growth promoting influences of estradiol, epidermal growth factor, and insulin on human breast cancer: evidence for differential mechanism of action on tumor cells in vitro. Breast Cancer Res Treat (1985) 0.78
Growth inhibitory effect of LH-RH analogs on human breast cancer cells. Anticancer Res (1988) 0.78
Role of stem cell transplantation in myeloma. Hematology (2005) 0.78
Estrogen binding by neoplastic human thymus cytosol. Eur J Cancer (1980) 0.78
Phosphoprotein phosphatase activity associated with estrogen-induced protein in rat uterus. Proc Natl Acad Sci U S A (1974) 0.78
Immunohistochemical expression of c-erbB-2 in human breast cancer by monoclonal antibody: correlation with lymph node and ER status. Tumori (1990) 0.78
Glucocorticoid receptor determinations in leukemia patients using cytosol and whole-cell assays. Cancer Res (1981) 0.78
Presence and steroid inducibility of glutamine synthetase in human leukemic cells. J Steroid Biochem (1983) 0.78
Elevated levels of circulating immunostimulatory 90K in Henoch-Schoenlein purpura. J Clin Immunol (1999) 0.77
The biosynthesis of triiphosphoinositide by purified myelin of peripheral nerve. J Neurochem (1969) 0.77
Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer. Anticancer Res (1990) 0.77
Advanced breast cancer: response to somatostatin. Anticancer Res (1990) 0.77